Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Invivyd ( (IVVD) ) has shared an announcement.
On July 2, 2025, Invivyd announced the formation of the SPEAR Study Group with leading researchers to assess the effects of monoclonal antibody therapy for Long COVID and COVID-19 Post-Vaccination Syndrome. This initiative aims to explore the potential of PEMGARDA, a monoclonal antibody, in providing symptom relief for Long COVID, a condition affecting a significant portion of the population. The study group will conduct rigorous clinical trials to evaluate the safety and efficacy of this therapy, potentially unlocking new treatment opportunities for patients and advancing Invivyd’s position in the COVID-19 therapeutic landscape.
The most recent analyst rating on (IVVD) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Invivyd stock, see the IVVD Stock Forecast page.
Spark’s Take on IVVD Stock
According to Spark, TipRanks’ AI Analyst, IVVD is a Neutral.
Invivyd’s overall stock score reflects significant financial and technical weaknesses, marked by ongoing losses and bearish trends. While recent corporate developments offer a glimpse of potential strategic improvement, these are overshadowed by the current financial instability and weak market sentiment.
To see Spark’s full report on IVVD stock, click here.
More about Invivyd
Invivyd, Inc. operates in the biotechnology industry, focusing on the development of monoclonal antibodies for the prevention and treatment of COVID-19. Their primary product, PEMGARDA, is an investigational monoclonal antibody authorized for emergency use in certain immunocompromised individuals for pre-exposure prophylaxis of COVID-19.
Average Trading Volume: 1,997,203
Technical Sentiment Signal: Sell
Current Market Cap: $86.52M
Find detailed analytics on IVVD stock on TipRanks’ Stock Analysis page.